Project Grant R61AG090394
Award Date
5/1/25
Completion Date
4/30/27
Dollars Obligated
$728K
Federal Agency
National Institute on Aging
Federal Grant Program
93.866
Assistance Type
Project Grant
Place of Performance
Missouri, USA
Similar Awards
This Project Grant award, provided by the National Institute on Aging under the Aging Research program (CFDA 93.866), will support the development of a novel, allogeneic cell-based therapy to address both tau-mediated pathology and associated inflammation in Alzheimer's disease and related dementias. The $734,778.00 grant awarded to the Regents of the University of Minnesota will fund research to engineer human induced pluripotent stem cell-derived macrophages with chimeric antigen receptors...
This federal Project Grant award from the National Institute on Aging (CFDA 93.866, Aging Research) provides $834,627 to the University of Florida to develop a novel "theranostic" (therapeutic and diagnostic) chimeric antigen receptor (CAR) T cell platform targeting cellular senescence, which plays a key role in Alzheimer's disease (AD) and other age-related disorders. The project aims to create a CAR T cell therapy that can selectively detect and eliminate senescent cells while...
This Project Grant award from the National Institute on Aging's Aging Research program (CFDA 93.866) provides $810,596 to New York University School of Medicine to develop an "off-the-shelf" chimeric antigen receptor (CAR) macrophage therapy for the treatment of Alzheimer's disease. The key products to be delivered under this 2-year award are: Optimization of protocols to efficiently differentiate human induced pluripotent stem cells (iPSCs) into inflammatory macrophage-like immune...
The National Institute on Aging (NIA) awarded a $613,571 Project Grant (CFDA 93.866 - Aging Research) to the University of Chicago to develop novel treatments for Alzheimer's disease (AD). The key objectives are to: 1) Develop chimeric antigen receptor (CAR) constructs that target amyloid-beta (Aβ) and promote microglial phagocytosis, and 2) Test whether lipid nanoparticles (LNPs) carrying mRNA encoding the anti-Aβ CAR and interleukin-10 (IL-10) can effectively transfect microglia in vivo to...
This federal Project Grant award in the amount of $374,000.00 from the National Institute on Aging (CFDA 93.866 - Aging Research) supports the development and evaluation of a hematopoietic stem cell-based chimeric antigen receptor (CAR) macrophage therapy targeting amyloid-beta aggregates for the treatment of Alzheimer's disease. The project aims to optimize the CAR-macrophage therapy for in vitro efficacy against amyloid-beta aggregates and inflammation reduction, as well as investigate its...
This Project Grant award from the National Institute on Aging's Aging Research federal grant program (CFDA 93.866) provides $871,419 to the University of Washington to conduct research on the role of microglia, the brain's immune cells, in the pathogenesis of Alzheimer's disease. The research aims to characterize molecular profiles and spatial organization of microglia across the adult age spectrum, both with and without Alzheimer's disease, through single-nucleus RNA sequencing of over 5,000...
This federal Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) provides $107,948.00 to the Regents of the University of Minnesota to investigate the role of regulatory T cells in Alzheimer's disease (AD). The award, which runs from November 16, 2024 to July 31, 2027, will address critical knowledge gaps by: 1) characterizing the types and spatial localization of regulatory T cells in the aging wild-type and AD mouse brains, and 2) establishing the effect...
This $239,758 Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) supports the development of a microphysiological system that models the brain-meninges-lymph node axis in both healthy conditions and an Alzheimer's disease model. The primary awardee, Virginia Polytechnic Institute & State University, will integrate tissue-engineered models of the human brain, lymph node, and meninges into a microfluidic platform to enable the study of neuroimmune...
This federal Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) provides $794,341 to the University of Illinois to investigate the roles of cellular senescence and blood-brain barrier dysfunction in Alzheimer's disease development and progression. The key objectives are to understand how viral and bacterial infections can initiate blood-brain barrier impairment and increase inflammation, leading to accelerated Alzheimer's disease pathology. The research...
This $125,896 Project Grant award from the National Institute on Aging's Aging Research program (CFDA 93.866) will support the genetic and single-cell multi-omic characterization of Alzheimer's disease (AD) risk and resilience pathways. The Washington University in St. Louis will utilize state-of-the-art single-nuclei multi-omic functional genomic analyses of healthy and AD human brain tissue, as well as transgenic AD mouse models, to perform deep molecular profiling across genetic,...